New function of calreticulin: Calreticulin-dependent mRNA destabilization

Circulation Research

Volumn 97, Issue 10, 2005, Pages 961-963

  Yokoyama, Mitsuhiro ^a   Hirata, Ken Ichi ^a  

^a KOBE UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Calreticulin; GLUTs; mRNA

Indexed keywords

CALRETICULIN; GLUCOSE TRANSPORTER; GLUCOSE TRANSPORTER 1; MESSENGER RNA;

3' UNTRANSLATED REGION; CARDIOVASCULAR SYSTEM; EDITORIAL; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN FUNCTION; PROTEIN RNA BINDING; RNA STABILITY;

3' UNTRANSLATED REGIONS; ANIMALS; CALCIUM SIGNALING; CALRETICULIN; GLUCOSE TRANSPORTER TYPE 1; HUMANS; RNA STABILITY; RNA, MESSENGER;

EID: 27944511091     PISSN: 00097330     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.RES.0000193564.46466.2a     Document Type: Editorial

References (8)

1. Johnson S, Michalak M, Opas M, Eggleton P. The ins and outs of calreticulin: from the ER lumen to the extracellular space. Trends Cell Biol. 2001;11:122-129.
2. Michalak M, Corbett EF, Mesaeli N, Nakamura K, Opas M. Calreticulin: one protein, one gene, many functions. Biochem J. 1999;344:281-292.
3. Nickenig G, Michaelsen F, Müller C, Berger A, Vogel T, Sachinidis A, Vetter H, Böhm M. Destabilization of AT1 receptor mRNA by calreticulin. Circ Res. 2002;90:53-58.
4. McGowan KM, Long SD, Pekala PH. Glucose transporter gene expression: Regulation of transcription and mRNA stability. Pharmac Ther. 1995;66:465-505.
5. Qi C, Pekala PH. Breakthroughs and views: The influence of mRNA stability on glucose transporter (GLUT1) gene expression. Biochem Biophys Res Commun. 1999;263:265-269.
6. Totary-Jain H, Naveh-MT, RiahiY, Kaiser N. Eckel J, Sasson S. Calreticulin destabilizes GLUT-1 mRNA in vascular endothelial and smooth muscle cells under high glucose conditions. Circulation Res. 2005;97:1001-1008.
7. Dai E, Stewart M, Ritchie B, Mesaeli N, Raha S, Kolodziejczyk D, Hobman ML, Liu LY, Etches W, Nation N, Michalak M, Lucas A. Calreticulin, a potential vascular regulatory protein, reduces intimal hyperplasia after arterial injury. Arterioscler Thromb Vasc Biol. 1997;17:2359-2368.
8. Michalak M, Lynch J, Groenendyk J, Guo L, Robert Parker JM, Opas M. Calreticulin in cardiac development and pathology. Biochim Biophys Acta. 2002;1600:32-37.